Rocket Lab USA, Inc. (RKLB) falls 10% on Neutron delay
Rocket Lab USA, Inc. (RKLB) falls 10% in after-hours trading after the company pushed Neutron’s first launch to 2027 because of manufacturing issues. The move follows a KeyBanc price-target cut and raises fresh questions about execution, even as Electron, HASTE, and space systems continue to support the business.
Rocket Lab USA, Inc. (RKLB) fell 10% in after-hours trading after the company pushed Neutron’s inaugural launch into 2027 because of manufacturing issues. The delay weakens the near-term growth case for Rocket Lab’s medium-lift rocket and triggered a sharper reassessment from investors, especially after KeyBanc cut its price target. For investors, the move signals an execution reset: the core business remains intact, but the stock now depends even more on Neutron delivery and future contract wins.
Rocket Lab USA, Inc. (RKLB) Falls 10% After Neutron Delay
Rocket Lab USA, Inc. (RKLB) falls 10% to $53.26 in after-hours trading, down from the prior regular-session close of $59.18. The sharp move follows the company’s Oct. 14 update that pushed Neutron’s inaugural launch into 2027 because of manufacturing issues. Regular-session trading will confirm whether the after-hours decline holds.
Key Takeaways
RKLB fell 10% in extended-hours trading, moving from $59.18 to $53.26.
The clearest catalyst is Rocket Lab’s decision to move Neutron’s first launch into 2027 due to manufacturing issues.
The company carries a $35.42B market cap while reported EPS stands at -$0.25, leaving the valuation tied heavily to future growth.
KeyBanc also cut its RKLB price target to $100 from $135 on Oct. 15, adding pressure to sentiment.
Investors should treat the move as an execution reset around Neutron, not as a routine pullback.
Rocket Lab’s Oct. 14 announcement is the central event behind the decline. The company adjusted Neutron’s inaugural launch timing to 2027 and linked the change to manufacturing issues. The market reacted quickly, with Investing.com reporting a 7% after-hours drop on Wednesday before the larger extended-hours move recorded at $53.26.
Neutron matters because it represents Rocket Lab’s move from small-lift launches into the medium-lift market. Electron gives the company an established small-lift rocket, but Neutron is the vehicle tied to a much larger long-term launch opportunity. A later first flight pushes back the timeline for that expansion and raises fresh questions about development execution.
Analyst activity added another headwind. KeyBanc lowered its price target to $100 from $135 on Oct. 15. That cut does not erase the broader bullish view, since the analyst consensus lists 16 Buy ratings, four Holds, and one Sell. Still, a target reduction on the same day as a major schedule setback gives sellers a second concrete reason to reassess the stock.
The shift also follows a period of strong optimism. RKLB’s seven-day news sentiment score was 0.8567, while its 30-day score was 0.8327. Those strongly positive readings show why a negative update on the company’s main growth project can produce an outsized reaction. Optimism creates fuel for rallies, but it also leaves more room for disappointment.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
How Rocket Lab USA, Inc.’s Financial Profile Shapes the Reaction
RKLB’s financial profile helps explain the severity of the selloff. The stock data lists EPS at -$0.25, so Rocket Lab remains an earnings-negative company. Its Aug. 10 earnings history showed EPS of -$0.06 against an estimate of -$0.07, a 14.3% positive surprise, but the result still represented a loss.
With a $35.42B market cap and negative EPS, traditional P/E analysis offers little support for the share price. Instead, investors have been valuing Rocket Lab on future launch capacity, space systems growth, contracts, and the potential scale of Neutron. That structure makes schedule news especially important. When the central growth asset moves further into the future, the market must reassess how long it will take for that asset to support earnings.
Volatility amplifies the reaction. RKLB carries a beta of 2.938, and its 52-week trading range runs from $37.57 to $151. The range shows that the stock already moves aggressively across changing expectations. Therefore, a company-specific delay can create a much larger price response than the same headline might produce in a mature aerospace company with positive earnings.
Rocket Lab’s Competitive Position Beyond the Neutron Delay
The Neutron setback does not remove Rocket Lab’s existing operating businesses. The company runs two main segments, launch services and space systems. Electron serves small-lift orbital missions, while the space-systems unit provides spacecraft components, manufacturing, optical systems, and related services.
Rocket Lab also has exposure to defense testing through HASTE, a suborbital platform designed for hypersonic work. Recent coverage cited a $190M deal for 20 HASTE flights under MACH-TB 2.0 and a $30M contract covering three Anduril launches. Those contracts give the company a defense-related growth channel while Neutron remains in development.
The company also announced a 20-launch Synspective deal, which previously supported positive momentum in the stock. These commitments reinforce the broader Rocket Lab story, but they do not solve the specific issue created by the Neutron delay. Electron, HASTE, and space systems can support the business today, while Neutron remains the major step toward a larger launch platform.
What the 2027 Neutron Delay Means for RKLB Investors
The most useful framework is to view this as an execution reset. Rocket Lab did not lose its Electron business, space-systems operations, or HASTE contracts. However, the company did move the first Neutron launch into 2027, and that change directly affects the timeline behind its medium-lift growth case.
Growth exposure: Neutron’s schedule now sits at the center of the valuation debate because the vehicle supports Rocket Lab’s medium-lift expansion.
Financial discipline: EPS remains negative at -$0.25, so investors should place greater weight on execution and cash demands than on near-term earnings multiples.
Price discipline: KeyBanc’s $100 target remains above the $53.26 extended-hours price, but analyst targets are forecasts rather than price floors.
The regular session is the practical test for the selloff. A sustained decline would show that investors are assigning more weight to execution risk, while a recovery would show that Electron, HASTE, and space systems still provide enough support for the broader growth thesis. Either way, the Neutron timeline now deserves more attention than short-term market noise.
RKLB falls because Rocket Lab pushed Neutron’s debut into 2027 after manufacturing issues, not because of a routine earnings fluctuation. The company retains meaningful businesses and contracts, but its $35.42B valuation remains closely linked to future execution. Investors should judge the next move against that reset, with regular-session trading confirming whether the after-hours decline holds.
RKLB is down because Rocket Lab delayed Neutron’s first launch to 2027 due to manufacturing issues. That setback hit sentiment and led investors to reassess the company’s growth timeline.
+Should I buy RKLB stock now?
The article suggests caution, not urgency. RKLB still has strong long-term potential, but the Neutron delay adds execution risk and the stock remains highly volatile.
+What caused Rocket Lab’s after-hours selloff?
The main catalyst was Rocket Lab’s update pushing Neutron’s inaugural launch into 2027. A KeyBanc price-target cut added another negative factor for traders.
+Does the Neutron delay hurt Rocket Lab’s long-term outlook?
Yes, it pushes back the timeline for Rocket Lab’s medium-lift expansion and delays a key part of the growth story. The company still has Electron, HASTE, and space-systems revenue, but investors will now focus more on execution.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on RKLB?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
